miR-124 targets many proteins like SCP1, Rho-associated protein kinase 1 (ROCK1), STAT3, matrix metallopeptidase 9 (MMP9), and inhibits tumor cell proliferation in GBM [4]. Here, MMP9 is linked to glioblastoma.